Variables |
Category |
Frequency |
Percent % |
Sex |
Male |
106 |
48.4 |
Female |
113 |
51.6 |
Age |
34 |
96 |
43.8 |
35-54 |
100 |
45.7 |
55 |
23 |
10.5 |
Smear result at enrolment |
Positive |
131 |
59.8 |
Negative |
77 |
35.2 |
Not indicated |
11 |
5.0 |
HIV status |
Positive |
72 |
32.9 |
Negative |
144 |
65.7 |
Refused |
3 |
1.4 |
Patient category |
Relapse |
159 |
72.6 |
Retreatment after failure |
43 |
19.6 |
Return after loss to follow-up |
17 |
7.8 |
Drug regimen used |
Category 1 (2ERHZ/4RH) |
111 |
50.7 |
Category 2 (2SERHZ/1ERHZ/5ERH |
108 |
49.3 |
Year of treatment |
2014 |
38 |
17.4 |
2015 |
58 |
26.5 |
2016 |
106 |
48.4 |
2017 |
17 |
7.8 |
AFB result at 2 and/or 3 month |
Positive |
54 |
24.7 |
Negative |
147 |
67.1 |
Not done |
16 |
7.3 |
Not indicated |
2 |
0.9 |
AFB result at 5th month |
Positive |
49 |
22.4 |
Negative |
160 |
73.1 |
Not done |
10 |
4.6 |
AFB result at 8th month |
Positive |
19 |
8.7 |
Negative |
194 |
88.6 |
Not done |
6 |
2.7 |
Treatment outcome |
Cured |
76 |
34.7 |
Treatment completed |
70 |
32.0 |
Treatment failure |
47 |
21.5 |
Defaulted |
1 |
0.5 |
Died |
5 |
2.3 |
Transferred out |
20 |
9.1 |